Qi Lu, Li Shuang, Xu Jun, Xu Jie, Lou Wangzouyang, Cheng Liangbin, Zhang Chizhi
Hubei University of Chinese Medicine, Wuhan 430061, China.
The Second People's Hospital of Yichang, Yichang 443000, China.
Gastroenterol Res Pract. 2020 Nov 27;2020:4054781. doi: 10.1155/2020/4054781. eCollection 2020.
Acupuncture is widely used in the clinical treatment of liver cirrhosis (LC) in China. However, the efficacy of acupuncture on LC has not been fully confirmed by systematic analysis. This current meta-analysis evaluated the impact effect of acupuncture on patients with LC. We conducted a systematic literature search of the China National Knowledge Infrastructure, the Chinese Biomedical Database (SinoMed), VIP medicine information system, Wanfang Data, PubMed, Cochrane Library, Web of Science, and Embase. Further, we used Review Manager 5.3 software for the analysis of the data and Stata 14.0 software for the Egger test to assess publication bias. Fifteen studies involving 1066 patients were included in the meta-analysis. The primary outcome was the efficacy rate of acupuncture therapy. The secondary outcomes were impact on acupuncture on liver function grading assessment and lab tests related to liver functions. The result suggested that acupuncture is an effective treatment option for patients with LC as a complementary therapy. However, the recommendation is weak due to some limitations of the included studies.
在中国,针灸被广泛应用于肝硬化(LC)的临床治疗。然而,针灸对LC的疗效尚未通过系统分析得到充分证实。本次荟萃分析评估了针灸对LC患者的影响效果。我们在中国知网、中国生物医学文献数据库(SinoMed)、维普医药信息系统、万方数据、PubMed、Cochrane图书馆、Web of Science和Embase中进行了系统的文献检索。此外,我们使用Review Manager 5.3软件进行数据分析,并使用Stata 14.0软件进行Egger检验以评估发表偏倚。荟萃分析纳入了15项研究,涉及1066例患者。主要结局是针灸治疗的有效率。次要结局是针灸对肝功能分级评估的影响以及与肝功能相关的实验室检查。结果表明,针灸作为一种辅助疗法,对LC患者是一种有效的治疗选择。然而,由于纳入研究存在一些局限性,该推荐力度较弱。